nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosaprepitant—Syncope—Paclitaxel—kidney cancer	0.000533	0.000533	CcSEcCtD
Fosaprepitant—Lethargy—Doxorubicin—kidney cancer	0.000533	0.000533	CcSEcCtD
Fosaprepitant—Hypersensitivity—Sunitinib—kidney cancer	0.000532	0.000532	CcSEcCtD
Fosaprepitant—Decreased appetite—Vincristine—kidney cancer	0.000531	0.000531	CcSEcCtD
Fosaprepitant—Pruritus—Sorafenib—kidney cancer	0.000531	0.000531	CcSEcCtD
Fosaprepitant—Vomiting—Erlotinib—kidney cancer	0.00053	0.00053	CcSEcCtD
Fosaprepitant—Erythema multiforme—Capecitabine—kidney cancer	0.00053	0.00053	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Vincristine—kidney cancer	0.000527	0.000527	CcSEcCtD
Fosaprepitant—Fatigue—Vincristine—kidney cancer	0.000527	0.000527	CcSEcCtD
Fosaprepitant—Rash—Erlotinib—kidney cancer	0.000526	0.000526	CcSEcCtD
Fosaprepitant—Dermatitis—Erlotinib—kidney cancer	0.000525	0.000525	CcSEcCtD
Fosaprepitant—Palpitations—Paclitaxel—kidney cancer	0.000525	0.000525	CcSEcCtD
Fosaprepitant—Hyponatraemia—Doxorubicin—kidney cancer	0.000524	0.000524	CcSEcCtD
Fosaprepitant—Insomnia—Gemcitabine—kidney cancer	0.000524	0.000524	CcSEcCtD
Fosaprepitant—Eye disorder—Capecitabine—kidney cancer	0.000524	0.000524	CcSEcCtD
Fosaprepitant—Headache—Erlotinib—kidney cancer	0.000523	0.000523	CcSEcCtD
Fosaprepitant—Tinnitus—Capecitabine—kidney cancer	0.000522	0.000522	CcSEcCtD
Fosaprepitant—Loss of consciousness—Paclitaxel—kidney cancer	0.000522	0.000522	CcSEcCtD
Fosaprepitant—Pain—Vincristine—kidney cancer	0.000522	0.000522	CcSEcCtD
Fosaprepitant—Constipation—Vincristine—kidney cancer	0.000522	0.000522	CcSEcCtD
Fosaprepitant—Osteoarthritis—Doxorubicin—kidney cancer	0.000522	0.000522	CcSEcCtD
Fosaprepitant—Cardiac disorder—Capecitabine—kidney cancer	0.00052	0.00052	CcSEcCtD
Fosaprepitant—Flushing—Capecitabine—kidney cancer	0.00052	0.00052	CcSEcCtD
Fosaprepitant—Cough—Paclitaxel—kidney cancer	0.000519	0.000519	CcSEcCtD
Fosaprepitant—Asthenia—Sunitinib—kidney cancer	0.000518	0.000518	CcSEcCtD
Fosaprepitant—Dyspnoea—Gemcitabine—kidney cancer	0.000517	0.000517	CcSEcCtD
Fosaprepitant—Nausea—Vinblastine—kidney cancer	0.000515	0.000515	CcSEcCtD
Fosaprepitant—Somnolence—Gemcitabine—kidney cancer	0.000515	0.000515	CcSEcCtD
Fosaprepitant—Nausea—Everolimus—kidney cancer	0.000513	0.000513	CcSEcCtD
Fosaprepitant—Diarrhoea—Sorafenib—kidney cancer	0.000513	0.000513	CcSEcCtD
Fosaprepitant—Hypertension—Paclitaxel—kidney cancer	0.000513	0.000513	CcSEcCtD
Fosaprepitant—Pruritus—Sunitinib—kidney cancer	0.000511	0.000511	CcSEcCtD
Fosaprepitant—Angiopathy—Capecitabine—kidney cancer	0.000508	0.000508	CcSEcCtD
Fosaprepitant—Immune system disorder—Capecitabine—kidney cancer	0.000506	0.000506	CcSEcCtD
Fosaprepitant—Chest pain—Paclitaxel—kidney cancer	0.000506	0.000506	CcSEcCtD
Fosaprepitant—Mediastinal disorder—Capecitabine—kidney cancer	0.000505	0.000505	CcSEcCtD
Fosaprepitant—Anxiety—Paclitaxel—kidney cancer	0.000504	0.000504	CcSEcCtD
Fosaprepitant—Decreased appetite—Gemcitabine—kidney cancer	0.000504	0.000504	CcSEcCtD
Fosaprepitant—Hypersensitivity—Dactinomycin—kidney cancer	0.000504	0.000504	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000503	0.000503	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.0005	0.0005	CcSEcCtD
Fosaprepitant—Discomfort—Paclitaxel—kidney cancer	0.0005	0.0005	CcSEcCtD
Fosaprepitant—Fatigue—Gemcitabine—kidney cancer	0.0005	0.0005	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Vincristine—kidney cancer	0.000499	0.000499	CcSEcCtD
Fosaprepitant—Dizziness—Sorafenib—kidney cancer	0.000496	0.000496	CcSEcCtD
Fosaprepitant—Constipation—Gemcitabine—kidney cancer	0.000495	0.000495	CcSEcCtD
Fosaprepitant—Pain—Gemcitabine—kidney cancer	0.000495	0.000495	CcSEcCtD
Fosaprepitant—Nausea—Erlotinib—kidney cancer	0.000495	0.000495	CcSEcCtD
Fosaprepitant—Dry mouth—Paclitaxel—kidney cancer	0.000495	0.000495	CcSEcCtD
Fosaprepitant—Diarrhoea—Sunitinib—kidney cancer	0.000494	0.000494	CcSEcCtD
Fosaprepitant—Mental disorder—Capecitabine—kidney cancer	0.000491	0.000491	CcSEcCtD
Fosaprepitant—Asthenia—Dactinomycin—kidney cancer	0.00049	0.00049	CcSEcCtD
Fosaprepitant—Erythema—Capecitabine—kidney cancer	0.000488	0.000488	CcSEcCtD
Fosaprepitant—Malnutrition—Capecitabine—kidney cancer	0.000488	0.000488	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Paclitaxel—kidney cancer	0.000485	0.000485	CcSEcCtD
Fosaprepitant—Oedema—Paclitaxel—kidney cancer	0.000485	0.000485	CcSEcCtD
Fosaprepitant—Abdominal pain—Vincristine—kidney cancer	0.000483	0.000483	CcSEcCtD
Fosaprepitant—Body temperature increased—Vincristine—kidney cancer	0.000483	0.000483	CcSEcCtD
Fosaprepitant—Infection—Paclitaxel—kidney cancer	0.000482	0.000482	CcSEcCtD
Fosaprepitant—Flatulence—Capecitabine—kidney cancer	0.000481	0.000481	CcSEcCtD
Fosaprepitant—Dysgeusia—Capecitabine—kidney cancer	0.000478	0.000478	CcSEcCtD
Fosaprepitant—Dizziness—Sunitinib—kidney cancer	0.000477	0.000477	CcSEcCtD
Fosaprepitant—Feeling abnormal—Gemcitabine—kidney cancer	0.000477	0.000477	CcSEcCtD
Fosaprepitant—Shock—Paclitaxel—kidney cancer	0.000477	0.000477	CcSEcCtD
Fosaprepitant—Vomiting—Sorafenib—kidney cancer	0.000477	0.000477	CcSEcCtD
Fosaprepitant—Abdominal pain upper—Doxorubicin—kidney cancer	0.000477	0.000477	CcSEcCtD
Fosaprepitant—Nervous system disorder—Paclitaxel—kidney cancer	0.000476	0.000476	CcSEcCtD
Fosaprepitant—Hypokalaemia—Doxorubicin—kidney cancer	0.000475	0.000475	CcSEcCtD
Fosaprepitant—Rash—Sorafenib—kidney cancer	0.000473	0.000473	CcSEcCtD
Fosaprepitant—Dermatitis—Sorafenib—kidney cancer	0.000473	0.000473	CcSEcCtD
Fosaprepitant—Skin disorder—Paclitaxel—kidney cancer	0.000471	0.000471	CcSEcCtD
Fosaprepitant—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.00047	0.00047	CcSEcCtD
Fosaprepitant—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.00047	0.00047	CcSEcCtD
Fosaprepitant—Headache—Sorafenib—kidney cancer	0.00047	0.00047	CcSEcCtD
Fosaprepitant—Muscle spasms—Capecitabine—kidney cancer	0.000469	0.000469	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Paclitaxel—kidney cancer	0.000469	0.000469	CcSEcCtD
Fosaprepitant—Diarrhoea—Dactinomycin—kidney cancer	0.000468	0.000468	CcSEcCtD
Fosaprepitant—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.00046	0.00046	CcSEcCtD
Fosaprepitant—Muscular weakness—Doxorubicin—kidney cancer	0.00046	0.00046	CcSEcCtD
Fosaprepitant—Vomiting—Sunitinib—kidney cancer	0.000459	0.000459	CcSEcCtD
Fosaprepitant—Body temperature increased—Gemcitabine—kidney cancer	0.000458	0.000458	CcSEcCtD
Fosaprepitant—Rash—Sunitinib—kidney cancer	0.000455	0.000455	CcSEcCtD
Fosaprepitant—Dermatitis—Sunitinib—kidney cancer	0.000455	0.000455	CcSEcCtD
Fosaprepitant—Abdominal distension—Doxorubicin—kidney cancer	0.000454	0.000454	CcSEcCtD
Fosaprepitant—Hypotension—Paclitaxel—kidney cancer	0.000453	0.000453	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Capecitabine—kidney cancer	0.000453	0.000453	CcSEcCtD
Fosaprepitant—Headache—Sunitinib—kidney cancer	0.000452	0.000452	CcSEcCtD
Fosaprepitant—Anaemia—Capecitabine—kidney cancer	0.000451	0.000451	CcSEcCtD
Fosaprepitant—Hypersensitivity—Vincristine—kidney cancer	0.00045	0.00045	CcSEcCtD
Fosaprepitant—Nausea—Sorafenib—kidney cancer	0.000446	0.000446	CcSEcCtD
Fosaprepitant—Malaise—Capecitabine—kidney cancer	0.00044	0.00044	CcSEcCtD
Fosaprepitant—Insomnia—Paclitaxel—kidney cancer	0.000439	0.000439	CcSEcCtD
Fosaprepitant—Asthenia—Vincristine—kidney cancer	0.000438	0.000438	CcSEcCtD
Fosaprepitant—Syncope—Capecitabine—kidney cancer	0.000437	0.000437	CcSEcCtD
Fosaprepitant—Vomiting—Dactinomycin—kidney cancer	0.000435	0.000435	CcSEcCtD
Fosaprepitant—Dyspnoea—Paclitaxel—kidney cancer	0.000432	0.000432	CcSEcCtD
Fosaprepitant—Somnolence—Paclitaxel—kidney cancer	0.000431	0.000431	CcSEcCtD
Fosaprepitant—Palpitations—Capecitabine—kidney cancer	0.000431	0.000431	CcSEcCtD
Fosaprepitant—Rash—Dactinomycin—kidney cancer	0.000431	0.000431	CcSEcCtD
Fosaprepitant—Nausea—Sunitinib—kidney cancer	0.000429	0.000429	CcSEcCtD
Fosaprepitant—Loss of consciousness—Capecitabine—kidney cancer	0.000429	0.000429	CcSEcCtD
Fosaprepitant—Dyspepsia—Paclitaxel—kidney cancer	0.000427	0.000427	CcSEcCtD
Fosaprepitant—Cough—Capecitabine—kidney cancer	0.000426	0.000426	CcSEcCtD
Fosaprepitant—Dysuria—Doxorubicin—kidney cancer	0.000422	0.000422	CcSEcCtD
Fosaprepitant—Decreased appetite—Paclitaxel—kidney cancer	0.000422	0.000422	CcSEcCtD
Fosaprepitant—Hypertension—Capecitabine—kidney cancer	0.000421	0.000421	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000419	0.000419	CcSEcCtD
Fosaprepitant—Fatigue—Paclitaxel—kidney cancer	0.000418	0.000418	CcSEcCtD
Fosaprepitant—Diarrhoea—Vincristine—kidney cancer	0.000418	0.000418	CcSEcCtD
Fosaprepitant—Pollakiuria—Doxorubicin—kidney cancer	0.000417	0.000417	CcSEcCtD
Fosaprepitant—Asthenia—Gemcitabine—kidney cancer	0.000416	0.000416	CcSEcCtD
Fosaprepitant—Chest pain—Capecitabine—kidney cancer	0.000415	0.000415	CcSEcCtD
Fosaprepitant—Pain—Paclitaxel—kidney cancer	0.000415	0.000415	CcSEcCtD
Fosaprepitant—Constipation—Paclitaxel—kidney cancer	0.000415	0.000415	CcSEcCtD
Fosaprepitant—Anxiety—Capecitabine—kidney cancer	0.000414	0.000414	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000412	0.000412	CcSEcCtD
Fosaprepitant—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000412	0.000412	CcSEcCtD
Fosaprepitant—Discomfort—Capecitabine—kidney cancer	0.00041	0.00041	CcSEcCtD
Fosaprepitant—Pruritus—Gemcitabine—kidney cancer	0.00041	0.00041	CcSEcCtD
Fosaprepitant—Weight decreased—Doxorubicin—kidney cancer	0.000408	0.000408	CcSEcCtD
Fosaprepitant—Dry mouth—Capecitabine—kidney cancer	0.000406	0.000406	CcSEcCtD
Fosaprepitant—Nausea—Dactinomycin—kidney cancer	0.000406	0.000406	CcSEcCtD
Fosaprepitant—Dizziness—Vincristine—kidney cancer	0.000404	0.000404	CcSEcCtD
Fosaprepitant—Infestation NOS—Doxorubicin—kidney cancer	0.000402	0.000402	CcSEcCtD
Fosaprepitant—Infestation—Doxorubicin—kidney cancer	0.000402	0.000402	CcSEcCtD
Fosaprepitant—Feeling abnormal—Paclitaxel—kidney cancer	0.0004	0.0004	CcSEcCtD
Fosaprepitant—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000399	0.000399	CcSEcCtD
Fosaprepitant—Oedema—Capecitabine—kidney cancer	0.000398	0.000398	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000397	0.000397	CcSEcCtD
Fosaprepitant—Diarrhoea—Gemcitabine—kidney cancer	0.000396	0.000396	CcSEcCtD
Fosaprepitant—Infection—Capecitabine—kidney cancer	0.000395	0.000395	CcSEcCtD
Fosaprepitant—Stomatitis—Doxorubicin—kidney cancer	0.000392	0.000392	CcSEcCtD
Fosaprepitant—Shock—Capecitabine—kidney cancer	0.000392	0.000392	CcSEcCtD
Fosaprepitant—Urinary tract infection—Doxorubicin—kidney cancer	0.000391	0.000391	CcSEcCtD
Fosaprepitant—Conjunctivitis—Doxorubicin—kidney cancer	0.000391	0.000391	CcSEcCtD
Fosaprepitant—Nervous system disorder—Capecitabine—kidney cancer	0.00039	0.00039	CcSEcCtD
Fosaprepitant—Vomiting—Vincristine—kidney cancer	0.000388	0.000388	CcSEcCtD
Fosaprepitant—Skin disorder—Capecitabine—kidney cancer	0.000387	0.000387	CcSEcCtD
Fosaprepitant—Urticaria—Paclitaxel—kidney cancer	0.000385	0.000385	CcSEcCtD
Fosaprepitant—Rash—Vincristine—kidney cancer	0.000385	0.000385	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Capecitabine—kidney cancer	0.000385	0.000385	CcSEcCtD
Fosaprepitant—Dermatitis—Vincristine—kidney cancer	0.000385	0.000385	CcSEcCtD
Fosaprepitant—Haematuria—Doxorubicin—kidney cancer	0.000384	0.000384	CcSEcCtD
Fosaprepitant—Body temperature increased—Paclitaxel—kidney cancer	0.000383	0.000383	CcSEcCtD
Fosaprepitant—Abdominal pain—Paclitaxel—kidney cancer	0.000383	0.000383	CcSEcCtD
Fosaprepitant—Headache—Vincristine—kidney cancer	0.000383	0.000383	CcSEcCtD
Fosaprepitant—Hypotension—Capecitabine—kidney cancer	0.000372	0.000372	CcSEcCtD
Fosaprepitant—Vomiting—Gemcitabine—kidney cancer	0.000368	0.000368	CcSEcCtD
Fosaprepitant—Bradycardia—Doxorubicin—kidney cancer	0.000368	0.000368	CcSEcCtD
Fosaprepitant—Rash—Gemcitabine—kidney cancer	0.000365	0.000365	CcSEcCtD
Fosaprepitant—Dermatitis—Gemcitabine—kidney cancer	0.000365	0.000365	CcSEcCtD
Fosaprepitant—Headache—Gemcitabine—kidney cancer	0.000363	0.000363	CcSEcCtD
Fosaprepitant—Nausea—Vincristine—kidney cancer	0.000363	0.000363	CcSEcCtD
Fosaprepitant—Insomnia—Capecitabine—kidney cancer	0.00036	0.00036	CcSEcCtD
Fosaprepitant—Hypoaesthesia—Doxorubicin—kidney cancer	0.000359	0.000359	CcSEcCtD
Fosaprepitant—Hypersensitivity—Paclitaxel—kidney cancer	0.000357	0.000357	CcSEcCtD
Fosaprepitant—Urinary tract disorder—Doxorubicin—kidney cancer	0.000357	0.000357	CcSEcCtD
Fosaprepitant—Connective tissue disorder—Doxorubicin—kidney cancer	0.000355	0.000355	CcSEcCtD
Fosaprepitant—Dyspnoea—Capecitabine—kidney cancer	0.000355	0.000355	CcSEcCtD
Fosaprepitant—Urethral disorder—Doxorubicin—kidney cancer	0.000354	0.000354	CcSEcCtD
Fosaprepitant—Dyspepsia—Capecitabine—kidney cancer	0.00035	0.00035	CcSEcCtD
Fosaprepitant—Asthenia—Paclitaxel—kidney cancer	0.000348	0.000348	CcSEcCtD
Fosaprepitant—Decreased appetite—Capecitabine—kidney cancer	0.000346	0.000346	CcSEcCtD
Fosaprepitant—Nausea—Gemcitabine—kidney cancer	0.000344	0.000344	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000344	0.000344	CcSEcCtD
Fosaprepitant—Fatigue—Capecitabine—kidney cancer	0.000343	0.000343	CcSEcCtD
Fosaprepitant—Pruritus—Paclitaxel—kidney cancer	0.000343	0.000343	CcSEcCtD
Fosaprepitant—Erythema multiforme—Doxorubicin—kidney cancer	0.000341	0.000341	CcSEcCtD
Fosaprepitant—Constipation—Capecitabine—kidney cancer	0.00034	0.00034	CcSEcCtD
Fosaprepitant—Pain—Capecitabine—kidney cancer	0.00034	0.00034	CcSEcCtD
Fosaprepitant—Eye disorder—Doxorubicin—kidney cancer	0.000338	0.000338	CcSEcCtD
Fosaprepitant—Tinnitus—Doxorubicin—kidney cancer	0.000337	0.000337	CcSEcCtD
Fosaprepitant—Flushing—Doxorubicin—kidney cancer	0.000335	0.000335	CcSEcCtD
Fosaprepitant—Cardiac disorder—Doxorubicin—kidney cancer	0.000335	0.000335	CcSEcCtD
Fosaprepitant—Diarrhoea—Paclitaxel—kidney cancer	0.000332	0.000332	CcSEcCtD
Fosaprepitant—Feeling abnormal—Capecitabine—kidney cancer	0.000328	0.000328	CcSEcCtD
Fosaprepitant—Angiopathy—Doxorubicin—kidney cancer	0.000328	0.000328	CcSEcCtD
Fosaprepitant—Immune system disorder—Doxorubicin—kidney cancer	0.000326	0.000326	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Capecitabine—kidney cancer	0.000326	0.000326	CcSEcCtD
Fosaprepitant—Mediastinal disorder—Doxorubicin—kidney cancer	0.000326	0.000326	CcSEcCtD
Fosaprepitant—Dizziness—Paclitaxel—kidney cancer	0.000321	0.000321	CcSEcCtD
Fosaprepitant—Mental disorder—Doxorubicin—kidney cancer	0.000316	0.000316	CcSEcCtD
Fosaprepitant—Urticaria—Capecitabine—kidney cancer	0.000316	0.000316	CcSEcCtD
Fosaprepitant—Abdominal pain—Capecitabine—kidney cancer	0.000315	0.000315	CcSEcCtD
Fosaprepitant—Body temperature increased—Capecitabine—kidney cancer	0.000315	0.000315	CcSEcCtD
Fosaprepitant—Erythema—Doxorubicin—kidney cancer	0.000314	0.000314	CcSEcCtD
Fosaprepitant—Malnutrition—Doxorubicin—kidney cancer	0.000314	0.000314	CcSEcCtD
Fosaprepitant—Flatulence—Doxorubicin—kidney cancer	0.00031	0.00031	CcSEcCtD
Fosaprepitant—Vomiting—Paclitaxel—kidney cancer	0.000308	0.000308	CcSEcCtD
Fosaprepitant—Dysgeusia—Doxorubicin—kidney cancer	0.000308	0.000308	CcSEcCtD
Fosaprepitant—Rash—Paclitaxel—kidney cancer	0.000306	0.000306	CcSEcCtD
Fosaprepitant—Dermatitis—Paclitaxel—kidney cancer	0.000306	0.000306	CcSEcCtD
Fosaprepitant—Headache—Paclitaxel—kidney cancer	0.000304	0.000304	CcSEcCtD
Fosaprepitant—Muscle spasms—Doxorubicin—kidney cancer	0.000302	0.000302	CcSEcCtD
Fosaprepitant—Hypersensitivity—Capecitabine—kidney cancer	0.000293	0.000293	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Doxorubicin—kidney cancer	0.000292	0.000292	CcSEcCtD
Fosaprepitant—Anaemia—Doxorubicin—kidney cancer	0.000291	0.000291	CcSEcCtD
Fosaprepitant—Nausea—Paclitaxel—kidney cancer	0.000288	0.000288	CcSEcCtD
Fosaprepitant—Asthenia—Capecitabine—kidney cancer	0.000286	0.000286	CcSEcCtD
Fosaprepitant—Malaise—Doxorubicin—kidney cancer	0.000284	0.000284	CcSEcCtD
Fosaprepitant—Syncope—Doxorubicin—kidney cancer	0.000282	0.000282	CcSEcCtD
Fosaprepitant—Pruritus—Capecitabine—kidney cancer	0.000282	0.000282	CcSEcCtD
Fosaprepitant—Palpitations—Doxorubicin—kidney cancer	0.000278	0.000278	CcSEcCtD
Fosaprepitant—Loss of consciousness—Doxorubicin—kidney cancer	0.000276	0.000276	CcSEcCtD
Fosaprepitant—Cough—Doxorubicin—kidney cancer	0.000274	0.000274	CcSEcCtD
Fosaprepitant—Diarrhoea—Capecitabine—kidney cancer	0.000272	0.000272	CcSEcCtD
Fosaprepitant—Hypertension—Doxorubicin—kidney cancer	0.000271	0.000271	CcSEcCtD
Fosaprepitant—Chest pain—Doxorubicin—kidney cancer	0.000268	0.000268	CcSEcCtD
Fosaprepitant—Anxiety—Doxorubicin—kidney cancer	0.000267	0.000267	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000266	0.000266	CcSEcCtD
Fosaprepitant—Discomfort—Doxorubicin—kidney cancer	0.000264	0.000264	CcSEcCtD
Fosaprepitant—Dizziness—Capecitabine—kidney cancer	0.000263	0.000263	CcSEcCtD
Fosaprepitant—Dry mouth—Doxorubicin—kidney cancer	0.000262	0.000262	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Doxorubicin—kidney cancer	0.000257	0.000257	CcSEcCtD
Fosaprepitant—Oedema—Doxorubicin—kidney cancer	0.000257	0.000257	CcSEcCtD
Fosaprepitant—Infection—Doxorubicin—kidney cancer	0.000255	0.000255	CcSEcCtD
Fosaprepitant—Vomiting—Capecitabine—kidney cancer	0.000253	0.000253	CcSEcCtD
Fosaprepitant—Shock—Doxorubicin—kidney cancer	0.000252	0.000252	CcSEcCtD
Fosaprepitant—Nervous system disorder—Doxorubicin—kidney cancer	0.000252	0.000252	CcSEcCtD
Fosaprepitant—Rash—Capecitabine—kidney cancer	0.000251	0.000251	CcSEcCtD
Fosaprepitant—Dermatitis—Capecitabine—kidney cancer	0.000251	0.000251	CcSEcCtD
Fosaprepitant—Headache—Capecitabine—kidney cancer	0.000249	0.000249	CcSEcCtD
Fosaprepitant—Skin disorder—Doxorubicin—kidney cancer	0.000249	0.000249	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Doxorubicin—kidney cancer	0.000248	0.000248	CcSEcCtD
Fosaprepitant—Hypotension—Doxorubicin—kidney cancer	0.00024	0.00024	CcSEcCtD
Fosaprepitant—Nausea—Capecitabine—kidney cancer	0.000236	0.000236	CcSEcCtD
Fosaprepitant—Insomnia—Doxorubicin—kidney cancer	0.000232	0.000232	CcSEcCtD
Fosaprepitant—Dyspnoea—Doxorubicin—kidney cancer	0.000229	0.000229	CcSEcCtD
Fosaprepitant—Somnolence—Doxorubicin—kidney cancer	0.000228	0.000228	CcSEcCtD
Fosaprepitant—Dyspepsia—Doxorubicin—kidney cancer	0.000226	0.000226	CcSEcCtD
Fosaprepitant—Decreased appetite—Doxorubicin—kidney cancer	0.000223	0.000223	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000222	0.000222	CcSEcCtD
Fosaprepitant—Fatigue—Doxorubicin—kidney cancer	0.000221	0.000221	CcSEcCtD
Fosaprepitant—Pain—Doxorubicin—kidney cancer	0.000219	0.000219	CcSEcCtD
Fosaprepitant—Constipation—Doxorubicin—kidney cancer	0.000219	0.000219	CcSEcCtD
Fosaprepitant—Feeling abnormal—Doxorubicin—kidney cancer	0.000211	0.000211	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Doxorubicin—kidney cancer	0.00021	0.00021	CcSEcCtD
Fosaprepitant—Urticaria—Doxorubicin—kidney cancer	0.000204	0.000204	CcSEcCtD
Fosaprepitant—Body temperature increased—Doxorubicin—kidney cancer	0.000203	0.000203	CcSEcCtD
Fosaprepitant—Abdominal pain—Doxorubicin—kidney cancer	0.000203	0.000203	CcSEcCtD
Fosaprepitant—Hypersensitivity—Doxorubicin—kidney cancer	0.000189	0.000189	CcSEcCtD
Fosaprepitant—Asthenia—Doxorubicin—kidney cancer	0.000184	0.000184	CcSEcCtD
Fosaprepitant—Pruritus—Doxorubicin—kidney cancer	0.000182	0.000182	CcSEcCtD
Fosaprepitant—Diarrhoea—Doxorubicin—kidney cancer	0.000176	0.000176	CcSEcCtD
Fosaprepitant—Dizziness—Doxorubicin—kidney cancer	0.00017	0.00017	CcSEcCtD
Fosaprepitant—Vomiting—Doxorubicin—kidney cancer	0.000163	0.000163	CcSEcCtD
Fosaprepitant—Rash—Doxorubicin—kidney cancer	0.000162	0.000162	CcSEcCtD
Fosaprepitant—Dermatitis—Doxorubicin—kidney cancer	0.000162	0.000162	CcSEcCtD
Fosaprepitant—Headache—Doxorubicin—kidney cancer	0.000161	0.000161	CcSEcCtD
Fosaprepitant—Nausea—Doxorubicin—kidney cancer	0.000152	0.000152	CcSEcCtD
